Fundraising FoxGladius Therapeutics
Philadelphia, US · Founded 2023 · Delaware corporation
Find your way into Gladius Therapeutics
Sign up to see every warm intro you have to Gladius Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Gladius Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MS
Michael SeidenNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$300K disclosed across 1 round · 2023
▶$300KraisedAug 2023 · 4 investors · Other Health CareRule 506(b)
▶$300KraisedAug 2023 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael SeidenExecutive Officer, Director, Promoter
- Offering amount
- $300K
- Amount sold
- $300K
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Gladius Therapeutics raised?
- Gladius Therapeutics has disclosed $300K raised across 1 round.
- Where is Gladius Therapeutics headquartered?
- Gladius Therapeutics is headquartered in Philadelphia, US.